(1) (a) How many of the 20 000 complementary medicines submitted by producers have been assessed and (b) what does this assessment entail; (2) whether any of these complementary medicines have been evaluated for (a) quality, (b) safety and (c) efficacy; if not, (i) why not and (ii) when will it be evaluated; if so, how many have (aa) been evaluated for each of these specified aspects and (bb) failed to meet the require standard of each of these specified aspects?